<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30192755</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>9</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Molecular epidemiology of enteroviruses in young children at increased risk of type 1 diabetes.</ArticleTitle><Pagination><StartPage>e0201959</StartPage><MedlinePgn>e0201959</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0201959</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0201959</ELocationID><Abstract><AbstractText Label="BACKGROUND">Young children are susceptible to enterovirus (EV) infections, which cause significant morbidity in this age group. However, the current knowledge regarding the epidemiology of EVs and the circulating virus strains is mostly based on viruses detected in children with severe diseases leading to contact with the health care system, while the vast reservoir of EVs that circulate in the general population is less characterized.</AbstractText><AbstractText Label="METHODOLOGY">The present study investigates the types and the prevalence of EVs circulating in the young children of the background population in Georgia, Colorado, and Washington State in the USA, and Germany, Sweden, and Finland in Europe. A total of 4018 stool samples, collected monthly from 300 healthy and non-hospitalized children at the age of 3-18 months in 2005-2009, were analyzed for the presence of EVs using RT-PCR, followed by sequencing of the VP1-2A region of the viral genome to type the EV(s) present. All of the children carried type HLA-DQ2 or -DQ8 alleles associated with type 1 diabetes.</AbstractText><AbstractText Label="PRINCIPAL FINDINGS">Altogether 201 children (67%) were found to be EV positive. The prevalence was much lower in Finnish children (26%) than in the children of the other counties combined (75%). Infections increased by age and showed a nadir during the winter months. Children who carried both the HLA-DQ2 and -DQ8 alleles had less infections than children who were homozygous for these alleles. Coxsackieviruses type A were the most frequently detected viruses in all geographical regions. Coxsackievirus type A4, Echovirus type 18, and Echovirus type 25 were shed for longer time periods than the other EV types.</AbstractText><AbstractText Label="CONCLUSIONS">Compared to prevalence data from symptomatic patients requiring medical attention, this study provides a better view of EVs circulating in young children in the USA and in Europe. The observations may prove useful for the selection of strategies for designing EV vaccines in the future. The study also confirms our previous serological findings suggesting that EV infections are relatively rare in Finland.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sioofy-Khojine</LastName><ForeName>Amir-Babak</ForeName><Initials>AB</Initials><Identifier Source="ORCID">0000-0001-5538-5153</Identifier><AffiliationInfo><Affiliation>Department of Virology, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oikarinen</LastName><ForeName>Sami</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Virology, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fimlab Laboratories, Pirkanmaa Hospital District, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honkanen</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Virology, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huhtala</LastName><ForeName>Heini</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Faculty of Social Sciences, University of Tampere, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehtonen</LastName><ForeName>Jussi P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Virology, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briese</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hy&#xf6;ty</LastName><ForeName>Heikki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Virology, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fimlab Laboratories, Pirkanmaa Hospital District, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>TEDDY Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR000064</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK100238</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001082</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK106955</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN267200700014C</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK112243</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UC4 DK117483</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003120" MajorTopicYN="N" Type="Geographic">Colorado</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005387" MajorTopicYN="N" Type="Geographic">Finland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005845" MajorTopicYN="N" Type="Geographic">Georgia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017720" MajorTopicYN="N">Molecular Epidemiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014861" MajorTopicYN="N" Type="Geographic">Washington</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>HH is a shareholder and chairman of the board of Vactech Ltd. (http://www.vactech.fi/en/), which develops vaccines against picornaviruses. There are no marketed products to declare, and this does not alter our adherence to PLOS ONE policies on sharing data and materials. All other authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30192755</ArticleId><ArticleId IdType="pmc">PMC6128458</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0201959</ArticleId><ArticleId IdType="pii">PONE-D-18-04002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA, Centers for Disease Control and Prevention. Enterovirus surveillance-United States, 1970&#x2013;2005. MMWR Surveill Summ 2006 Sep 15;55(8):1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">16971890</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallansch M, Oberste M, Whitton J. Enteroviruses: polioviruses, coxsakieviruses, echoviruses, and newer enteroviruses In: Knipe D, Howley P, editors. Fields virology. 6th ed ed.: Lippincott Williams &amp; Wilkins, Philadelphia, PA; 2013. p. 490&#x2013;530.</Citation></Reference><Reference><Citation>Zell R, Delwart E, Gorbalenya AE, Hovi T, King AMQ, Knowles NJ, et al. ICTV Virus Taxonomy Profile: Picornaviridae. J Gen Virol 2017. October;98(10):2421&#x2013;2422. 10.1099/jgv.0.000911</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000911</ArticleId><ArticleId IdType="pmc">PMC5725991</ArticleId><ArticleId IdType="pubmed">28884666</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnick JL. Enteroviruses In: Fields BN, Knipe DM, Chanock RM, Hirch MS, Melnick JL, Monath TP, Roizman B, editor. 2nd ed. New York: Raven Press; 1990. p. 590.</Citation></Reference><Reference><Citation>Pallansch M, Oberste M. Coxsackievirus, echovirus, and other enteroviruses In: Gorbach S, Bartlett J, Blacklow N, editors. Infectious diseases.: Philadelphia: Lippincott, Williams and Wilkins; 2003. p. 2347&#x2013;2053.</Citation></Reference><Reference><Citation>Tan Y, Hassan F, Schuster JE, Simenauer A, Selvarangan R, Halpin RA, et al. Molecular Evolution and Intraclade Recombination of Enterovirus D68 during the 2014 Outbreak in the United States. J Virol 2015. December 9;90(4):1997&#x2013;2007. 10.1128/JVI.02418-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02418-15</ArticleId><ArticleId IdType="pmc">PMC4733988</ArticleId><ArticleId IdType="pubmed">26656685</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipson SM, Walderman R, Costello P, Szabo K. Sensitivity of rhabdomyosarcoma and guinea pig embryo cell cultures to field isolates of difficult-to-cultivate group A coxsackieviruses. J Clin Microbiol 1988. July;26(7):1298&#x2013;1303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC266596</ArticleId><ArticleId IdType="pubmed">2842370</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt NJ, Ho HH, Lennette EH. Propagation and isolation of group A coxsackieviruses in RD cells. J Clin Microbiol 1975. September;2(3):183&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC274168</ArticleId><ArticleId IdType="pubmed">1176625</ArticleId></ArticleIdList></Reference><Reference><Citation>Landry ML, Madore HP, Fong CK, Hsiung GD. Use of guinea pig embryo cell cultures for isolation and propagation of group A coxsackieviruses. J Clin Microbiol 1981. March;13(3):588&#x2013;593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC273834</ArticleId><ArticleId IdType="pubmed">6263943</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang PS, Huang ML, Luo ST, Lin TY, Tsao KC, Lee MS. Comparing molecular methods for early detection and serotyping of enteroviruses in throat swabs of pediatric patients. PLoS One 2012;7(10):e48269 10.1371/journal.pone.0048269</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0048269</ArticleId><ArticleId IdType="pmc">PMC3484998</ArticleId><ArticleId IdType="pubmed">23133580</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsao LY, Lin CY, Yu YY, Wang BT. Microchip, reverse transcription-polymerase chain reaction and culture methods to detect enterovirus infection in pediatric patients. Pediatr Int 2006. February;48(1):5&#x2013;10. 10.1111/j.1442-200X.2006.02157.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-200X.2006.02157.x</ArticleId><ArticleId IdType="pubmed">16490062</ArticleId></ArticleIdList></Reference><Reference><Citation>Vuorinen T, Vainionpaa R, Hyypia T. Five years' experience of reverse-transcriptase polymerase chain reaction in daily diagnosis of enterovirus and rhinovirus infections. Clin Infect Dis 2003. August 1;37(3):452&#x2013;455. 10.1086/376635</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/376635</ArticleId><ArticleId IdType="pubmed">12884172</ArticleId></ArticleIdList></Reference><Reference><Citation>Nix WA, Oberste MS, Pallansch MA. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol 2006. August;44(8):2698&#x2013;2704. 10.1128/JCM.00542-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00542-06</ArticleId><ArticleId IdType="pmc">PMC1594621</ArticleId><ArticleId IdType="pubmed">16891480</ArticleId></ArticleIdList></Reference><Reference><Citation>Nix WA, Oberste MS, Pallansch MA. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol 2006. August;44(8):2698&#x2013;2704. 10.1128/JCM.00542-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00542-06</ArticleId><ArticleId IdType="pmc">PMC1594621</ArticleId><ArticleId IdType="pubmed">16891480</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyoty H. Viruses in type 1 diabetes. Pediatr Diabetes 2016. July;17 Suppl 22:56&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">27411438</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011. February 3;342:d35 10.1136/bmj.d35</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d35</ArticleId><ArticleId IdType="pmc">PMC3033438</ArticleId><ArticleId IdType="pubmed">21292721</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagopian WA, Erlich H, Lernmark A, Rewers M, Ziegler AG, Simell O, et al. The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes 2011. December;12(8):733&#x2013;743. 10.1111/j.1399-5448.2011.00774.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-5448.2011.00774.x</ArticleId><ArticleId IdType="pmc">PMC3315186</ArticleId><ArticleId IdType="pubmed">21564455</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonnrot M, Lynch K, Larsson HE, Lernmark A, Rewers M, Hagopian W, et al. A method for reporting and classifying acute infectious diseases in a prospective study of young children: TEDDY. BMC Pediatr 2015. March 20;15:24-015-0333-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4377063</ArticleId><ArticleId IdType="pubmed">25884839</ArticleId></ArticleIdList></Reference><Reference><Citation>Honkanen H, Oikarinen S, Nurminen N, Laitinen OH, Huhtala H, Lehtonen J, et al. Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity. Diabetologia 2017. March;60(3):424&#x2013;431. 10.1007/s00125-016-4177-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-016-4177-z</ArticleId><ArticleId IdType="pubmed">28070615</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroneman A, Vennema H, Deforche K, v d Avoort H, Penaranda S, Oberste MS, et al. An automated genotyping tool for enteroviruses and noroviruses. J Clin Virol 2011. June;51(2):121&#x2013;125. 10.1016/j.jcv.2011.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2011.03.006</ArticleId><ArticleId IdType="pubmed">21514213</ArticleId></ArticleIdList></Reference><Reference><Citation>Abedi GR, Watson JT, Pham H, Nix WA, Oberste MS, Gerber SI. Enterovirus and Human Parechovirus Surveillance&#x2014;United States, 2009&#x2013;2013. MMWR Morb Mortal Wkly Rep
2015. 
September
4;64(34):940&#x2013;943. doi: 10.15585/mmwr.mm6434a3
</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6434a3</ArticleId><ArticleId IdType="pubmed">26334674</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC). Nonpolio enterovirus and human parechovirus surveillance&#x2014;United States, 2006&#x2013;2008. MMWR Morb Mortal Wkly Rep 2010. December 10;59(48):1577&#x2013;1580.</Citation><ArticleIdList><ArticleId IdType="pubmed">21150865</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC U. The National Enterovirus Surveillance System (NESS), USA. March 11, 2016; Available at: https://www.cdc.gov/surveillance/ness/index.html. Accessed 04/16, 2018.</Citation></Reference><Reference><Citation>Ryu WS, Kang B, Hong J, Hwang S, Kim J, Cheon DS. Clinical and etiological characteristics of enterovirus 71-related diseases during a recent 2-year period in Korea. J Clin Microbiol 2010. July;48(7):2490&#x2013;2494. 10.1128/JCM.02369-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02369-09</ArticleId><ArticleId IdType="pmc">PMC2897491</ArticleId><ArticleId IdType="pubmed">20463159</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YF, Yang F, Du J, Dong J, Zhang T, Wu ZQ, et al. Complete genome analysis of coxsackievirus A2, A4, A5, and A10 strains isolated from hand, foot, and mouth disease patients in China revealing frequent recombination of human enterovirus A. J Clin Microbiol 2011. July;49(7):2426&#x2013;2434. 10.1128/JCM.00007-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00007-11</ArticleId><ArticleId IdType="pmc">PMC3147834</ArticleId><ArticleId IdType="pubmed">21543560</ArticleId></ArticleIdList></Reference><Reference><Citation>Tryfonos C, Richter J, Koptides D, Yiangou M, Christodoulou CG. Molecular typing and epidemiology of enteroviruses in Cyprus, 2003&#x2013;2007. J Med Microbiol 2011. October;60(Pt 10):1433&#x2013;1440. 10.1099/jmm.0.029892-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.029892-0</ArticleId><ArticleId IdType="pubmed">21596905</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopalkrishna V, Patil PR, Patil GP, Chitambar SD. Circulation of multiple enterovirus serotypes causing hand, foot and mouth disease in India. J Med Microbiol 2012. March;61(Pt 3):420&#x2013;425. 10.1099/jmm.0.036400-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.036400-0</ArticleId><ArticleId IdType="pubmed">22052995</ArticleId></ArticleIdList></Reference><Reference><Citation>Duintjer Tebbens RJ, Pallansch MA, Kew OM, Caceres VM, Sutter RW, Thompson KM. A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future. Am J Epidemiol 2005. August 15;162(4):358&#x2013;372. 10.1093/aje/kwi206</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwi206</ArticleId><ArticleId IdType="pubmed">16014773</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonen-Tikka ML, Hiekka AK, Klemola P, Poussa T, Ludvigsson J, Korpela R, et al. Early human enterovirus infections in healthy Swedish children participating in the PRODIA pilot study. J Med Virol 2012. June;84(6):923&#x2013;930. 10.1002/jmv.23284</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23284</ArticleId><ArticleId IdType="pubmed">22499016</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonen-Tikka ML, Pflueger M, Klemola P, Savolainen-Kopra C, Smura T, Hummel S, et al. Human enterovirus infections in children at increased risk for type 1 diabetes: the Babydiet study. Diabetologia 2011. December;54(12):2995&#x2013;3002. 10.1007/s00125-011-2305-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-011-2305-3</ArticleId><ArticleId IdType="pubmed">21932150</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapia G, Cinek O, Rasmussen T, Witso E, Grinde B, Stene LC, et al. Human enterovirus RNA in monthly fecal samples and islet autoimmunity in Norwegian children with high genetic risk for type 1 diabetes: the MIDIA study. Diabetes Care 2011. January;34(1):151&#x2013;155. 10.2337/dc10-1413</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc10-1413</ArticleId><ArticleId IdType="pmc">PMC3005474</ArticleId><ArticleId IdType="pubmed">20929993</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung PW, Huang YC, Chang LY, Lin TY, Ning HC. Duration of enterovirus shedding in stool. J Microbiol Immunol Infect 2001. September;34(3):167&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">11605806</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J, Ma XJ, Wan JF, Liu YH, Han YL, Chen C, et al. Long persistence of EV71 specific nucleotides in respiratory and feces samples of the patients with Hand-Foot-Mouth Disease after recovery. BMC Infect Dis 2010. June 18;10:178-2334-10-178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2895604</ArticleId><ArticleId IdType="pubmed">20565813</ArticleId></ArticleIdList></Reference><Reference><Citation>Viskari H, Ludvigsson J, Uibo R, Salur L, Marciulionyte D, Hermann R, et al. Relationship between the incidence of type 1 diabetes and enterovirus infections in different European populations: results from the EPIVIR project. J Med Virol 2004. April;72(4):610&#x2013;617. 10.1002/jmv.20033</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20033</ArticleId><ArticleId IdType="pubmed">14981763</ArticleId></ArticleIdList></Reference><Reference><Citation>Seiskari T, Kondrashova A, Viskari H, Kaila M, Haapala AM, Aittoniemi J, et al. Allergic sensitization and microbial load&#x2014;a comparison between Finland and Russian Karelia. Clin Exp Immunol 2007. April;148(1):47&#x2013;52. 10.1111/j.1365-2249.2007.03333.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2007.03333.x</ArticleId><ArticleId IdType="pmc">PMC1868862</ArticleId><ArticleId IdType="pubmed">17302731</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M, Oberste MS, Pallansch MA, Abedi GR, Takahashi S, Grenfell BT, et al. The seasonality of nonpolio enteroviruses in the United States: Patterns and drivers. Proc Natl Acad Sci U S A 2018. March 20;115(12):3078&#x2013;3083. 10.1073/pnas.1721159115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1721159115</ArticleId><ArticleId IdType="pmc">PMC5866597</ArticleId><ArticleId IdType="pubmed">29507246</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller E, Gay N. Effect of age on outcome and epidemiology of infectious diseases. Biologicals 1997. June;25(2):137&#x2013;142. 10.1006/biol.1997.0072</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/biol.1997.0072</ArticleId><ArticleId IdType="pubmed">9236040</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathanson N, Martin JR. The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. Am J Epidemiol 1979. December;110(6):672&#x2013;692.</Citation><ArticleIdList><ArticleId IdType="pubmed">400274</ArticleId></ArticleIdList></Reference><Reference><Citation>Viskari HR, Koskela P, Lonnrot M, Luonuansuu S, Reunanen A, Baer M, et al. Can enterovirus infections explain the increasing incidence of type 1 diabetes? Diabetes Care 2000. March;23(3):414&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pubmed">10868874</ArticleId></ArticleIdList></Reference><Reference><Citation>Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007. August 17;317(5840):944&#x2013;947. 10.1126/science.1143767</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1143767</ArticleId><ArticleId IdType="pmc">PMC1991296</ArticleId><ArticleId IdType="pubmed">17641165</ArticleId></ArticleIdList></Reference><Reference><Citation>Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, Cirulli ET, et al. Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009. December;5(12):e1000791 10.1371/journal.pgen.1000791</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000791</ArticleId><ArticleId IdType="pmc">PMC2791220</ArticleId><ArticleId IdType="pubmed">20041166</ArticleId></ArticleIdList></Reference><Reference><Citation>International HIV Controllers Study, Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010. December 10;330(6010):1551&#x2013;1557. 10.1126/science.1195271</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1195271</ArticleId><ArticleId IdType="pmc">PMC3235490</ArticleId><ArticleId IdType="pubmed">21051598</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeharju K, Knip M, Hiltunen M, Akerblom HK, Hyoty H. The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens. Diabetologia 2003. August;46(8):1100&#x2013;1105. 10.1007/s00125-003-1157-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-003-1157-x</ArticleId><ArticleId IdType="pubmed">12845430</ArticleId></ArticleIdList></Reference><Reference><Citation>Hraber P, Kuiken C, Yusim K. Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection. Hepatology 2007. December;46(6):1713&#x2013;1721. 10.1002/hep.21889</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.21889</ArticleId><ArticleId IdType="pubmed">17935228</ArticleId></ArticleIdList></Reference><Reference><Citation>Magaret A, Dong L, John M, Mallal SA, James I, Warren T, et al. HLA Class I and II alleles, heterozygosity and HLA-KIR interactions are associated with rates of genital HSV shedding and lesions. Genes Immun 2016. December;17(7):412&#x2013;418. 10.1038/gene.2016.42</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2016.42</ArticleId><ArticleId IdType="pmc">PMC5133162</ArticleId><ArticleId IdType="pubmed">27853144</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>